Molecular and Cellular Mechanisms of Sarcopenia: Integrating Fiber‐Type Remodeling, Contractile Protein Dynamics, and Systemic Regulatory Pathways
Cell Biochemistry and Function · 2026
DOI: 10.1002/cbf.70194 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, 2026. Written by Nikam Rutuja Dilesh and 3 co-authors. Institution: Department of Pharmacology and Toxicology, Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research, Raebarel…. Major MEDLINE topics: Sarcopenia, Contractile Proteins. Cited 2 times so far (Crossref); 299 references. Funded by: Department of Chemicals and Petrochemicals, Ministry of Chemicals and Fertilizers, India.
Abstract (original language)
Sarcopenia is an age‐associated skeletal muscle disorder characterized by progressive declines in muscle mass, strength, and functional performance. A central feature of sarcopenic remodeling is the preferential loss of fast‐twitch (Type II) fibers and alterations in contractile protein composition, leading to reduced force generation and impaired muscle quality. Maintenance of skeletal muscle function depends on the integrity of the contractile apparatus, including myosin heavy chain isoforms, titin, actin, troponin, and associated structural proteins, which undergo quantitative and qualitative changes with aging. Multiple aging‐related mechanisms including telomere attrition, epigenetic remodeling, mitochondrial dysfunction, ionic dyshomeostasis, hormonal alterations, and chronic low‐grade inflammation converge on fiber‐type regulation and sarcomeric stability. These upstream processes impair satellite cell renewal, disrupt excitation–contraction coupling, accelerate proteolysis of contractile proteins, and promote maladaptive fiber‐type transitions. Ankyrins and muscle ankyrin repeat proteins (MARPs) further modulate sarcomere organization, mechanotransduction, and adaptive stress signaling. Age‐related dysregulation of ankyrin–contractile protein interactions compromises structural stability and regenerative capacity, contributing to muscle weakness and frailty. Viewing sarcopenia through the integrated framework of fiber‐type plasticity, contractile protein dynamics, and ankyrin‐mediated regulation provides a unifying mechanistic perspective that links systemic aging processes to structural muscle decline. This approach highlights potential biomarkers and therapeutic targets for preserving muscle function in aging populations.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology and Toxicology, Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Lucknow, Uttar Pradesh, India.
- Department of Pharmacy, Birla Institute of Technology and Science, Pilani Campus, Vidya Vihar, Pilani, Rajasthan, India.
ORCID profiles: Sapana Kushwaha
Funding
- Department of Chemicals and Petrochemicals, Ministry of Chemicals and Fertilizers, India
Cite
APA
Dilesh, N. R., Khatri, D., Shrivastava, R., & Kushwaha, S. (2026). Molecular and Cellular Mechanisms of Sarcopenia: Integrating Fiber‐Type Remodeling, Contractile Protein Dynamics, and Systemic Regulatory Pathways. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70194
Vancouver
Dilesh NR, Khatri D, Shrivastava R, Kushwaha S. Molecular and Cellular Mechanisms of Sarcopenia: Integrating Fiber‐Type Remodeling, Contractile Protein Dynamics, and Systemic Regulatory Pathways. Cell Biochemistry and Function. 2026. doi:10.1002/cbf.70194
BibTeX
@article{Dilesh2026,
author = {Dilesh, Nikam Rutuja and Khatri, Divyansh and Shrivastava, Richa and Kushwaha, Sapana},
title = {Molecular and Cellular Mechanisms of Sarcopenia: Integrating Fiber‐Type Remodeling, Contractile Protein Dynamics, and Systemic Regulatory Pathways},
journal = {Cell Biochemistry and Function},
year = {2026},
doi = {10.1002/cbf.70194}
}
EUVIMED